PROJECT HEMOREGEN-721 | SYNTHETIC BLOOD ENGINEERING BLUEPRINT

Comprehensive Architecture for Artificial Blood Systems, Programmable Blood Components, Cell-Free Blood Therapeutics, and Next-Generation Universal Blood Replacement Platforms

Program Code: HEMOREGEN-BLD-006

Division: HEMOREGEN-BLD-500

Parent Program: HEMOREGEN-BLD-000

Classification: Synthetic Blood Systems Engineering Platform

Status: Master Engineering Blueprint v1.0

EXECUTIVE SUMMARY

The Synthetic Blood Engineering Blueprint establishes the foundational framework for the design, development, manufacturing, and clinical translation of next-generation synthetic blood systems.

Within PROJECT HEMOREGEN-721, synthetic blood is not defined merely as an oxygen carrier but as a fully integrated biological support ecosystem capable of reproducing critical blood functions:

Oxygen transport
Carbon dioxide transport
Hemostasis
Immune support
Regenerative signaling
Organ communication
Metabolic stabilization
Homeostatic coordination

The long-term objective is the development of a Universal Programmable Blood Platform capable of functioning independently or synergistically with native blood systems.

SECTION I — SCF SYNTHETIC BLOOD HYPOTHESIS

Core Principle

Blood possesses five essential functional domains:

Domain A

Transport

Functions:

Oxygen delivery
Carbon dioxide removal

Domain B

Protection

Functions:

Hemostasis
Barrier stabilization

Domain C

Defense

Functions:

Immune surveillance
Pathogen response

Domain D

Regeneration

Functions:

Repair coordination
Tissue restoration

Domain E

Communication

Functions:

EV signaling
Organ coordination

Synthetic blood systems must progressively replicate each domain.

SECTION II — UNIVERSAL SYNTHETIC BLOOD ARCHITECTURE

Tier I

Synthetic Oxygen Layer

Function:

Gas transport.

Tier II

Synthetic Hemostatic Layer

Function:

Vascular repair.

Tier III

Synthetic Communication Layer

Function:

Information transfer.

Tier IV

Synthetic Regenerative Layer

Function:

Repair support.

Tier V

Synthetic Intelligence Layer

Function:

Adaptive response.

SECTION III — SYNTHETIC ERYTHROCYTE SYSTEMS

Program Designation

HEM-SYN-RBC-001

Objective

Create artificial oxygen-carrying systems.

Functional Requirements

Oxygen Binding

Equivalent oxygen transport capability.

Carbon Dioxide Handling

Physiological gas exchange support.

Microcirculatory Transit

Capillary passage compatibility.

Storage Stability

Extended shelf life.

Engineering Platforms

Platform A

Hemoglobin-Based Systems

Components:

Encapsulated oxygen carriers
Stabilized hemoglobin complexes

Platform B

Perfluorocarbon-Based Systems

Components:

Dissolved oxygen carriers

Platform C

Bioengineered Synthetic RBCs

Components:

Biomimetic membranes
Artificial cytoskeletal systems

SCF Engineering Objectives

Universal compatibility
Reduced immunogenicity
Extended circulation time
Enhanced oxygen delivery precision

SECTION IV — SYNTHETIC PLATELET SYSTEMS

Program Designation

HEM-SYN-PLT-001

Objective

Create programmable hemostatic particles.

Functional Requirements

Injury Recognition

Detect vascular disruption.

Adhesion

Localize to injury sites.

Clot Support

Promote physiological hemostasis.

Controlled Resolution

Avoid excessive thrombosis.

Engineering Platforms

Platform A

Nanoparticle Hemostatic Systems

Platform B

Biomimetic Platelet Constructs

Platform C

Programmable Clotting Particles

Target Applications

Trauma
Surgery
Battlefield medicine
Remote medicine

SECTION V — SYNTHETIC EV COMMUNICATION SYSTEMS

Program Designation

HEM-SYN-EV-001

Objective

Create artificial biological communication systems.

Functional Requirements

Message Packaging

Programmable information loading.

Address Coding

Target-specific routing.

Message Delivery

Controlled release.

Signal Interpretation

Predictable biological response.

Communication Cargo Classes

Cargo Class A

Regenerative Messages

Functions:

Tissue repair

Cargo Class B

Immune Messages

Functions:

Immune modulation

Cargo Class C

Hematopoietic Messages

Functions:

Blood regeneration

Cargo Class D

Metabolic Messages

Functions:

Homeostasis support

SECTION VI — SYNTHETIC IMMUNE SUPPORT SYSTEMS

Program Designation

HEM-SYN-IMM-001

Objective

Provide temporary immune-support functions.

Functional Domains

Threat Recognition Support

Inflammatory Modulation

Cytokine Buffering

Tolerance Stabilization

Future Development

Cell-free immune communication platforms.

SECTION VII — SYNTHETIC REGENERATIVE SYSTEMS

Program Designation

HEM-SYN-REGEN-001

Objective

Provide regenerative support functions.

Functional Modules

Module A

Stem Cell Recruitment Support

Module B

Repair Signaling Systems

Module C

Fibrosis Prevention Systems

Module D

Organ Protection Systems

SECTION VIII — UNIVERSAL PROGRAMMABLE BLOOD PLATFORM

Program Designation

HEM-SYN-UPB-001

Vision

Create a modular blood ecosystem.

Modular Components

Module	Function
O2 Module	Oxygen transport
HEM Module	Hemostasis
IMM Module	Immune support
EV Module	Communication
REG Module	Regeneration

Deployment Models

Configuration A

Oxygen Support Blood

Configuration B

Trauma Support Blood

Configuration C

Regenerative Blood

Configuration D

Immune Support Blood

Configuration E

Full Synthetic Blood

SECTION IX — UNIVERSAL BLOOD COMPATIBILITY FRAMEWORK

Objective

Develop universally deployable blood systems.

Design Principles

Principle 1

ABO-independent functionality

Principle 2

Reduced immunogenicity

Principle 3

Extended storage

Principle 4

Rapid deployment

Principle 5

Global scalability

SECTION X — SYNTHETIC BLOOD FAILURE ARCHITECTURE

SBF-1

Transport Failure

SBF-2

Hemostatic Failure

SBF-3

Communication Failure

SBF-4

Immune Compatibility Failure

SBF-5

Regenerative Failure

SBF-6

System Integration Failure

SECTION XI — SCF SYNTHETIC BLOOD PERFORMANCE INDEX

Universal Synthetic Blood Index (USBI)

Domain	Score
Oxygen Performance	0–20
Hemostatic Performance	0–20
Communication Capability	0–20
Regenerative Capability	0–20
Safety & Compatibility	0–20

Total:

0–100

Score	Interpretation
80–100	Advanced synthetic blood system
60–79	Functional blood substitute
40–59	Partial blood support system
20–39	Limited-use platform
<20	Non-viable system

SECTION XII — SCF UNIVERSAL BLOOD ENGINEERING STRATEGY

Phase I

Synthetic Component Development

Deliverables:

Synthetic RBCs
Synthetic platelets
Synthetic EVs

Phase II

Integrated Blood Modules

Deliverables:

Multi-function blood constructs

Phase III

Programmable Blood Systems

Deliverables:

Adaptive blood architectures

Phase IV

Universal Blood Platforms

Deliverables:

Global blood replacement systems

Phase V

Synthetic Blood Intelligence Systems

Deliverables:

AI-integrated programmable blood

SECTION XIII — HEMOREGEN THERAPEUTIC ENGINEERING BLUEPRINT

HEM-BLD-RX-016

Synthetic Oxygen Carrier Platform

HEM-BLD-RX-017

Synthetic Hemostasis Platform

HEM-BLD-RX-018

Synthetic EV Communication Platform

HEM-BLD-RX-019

Programmable Blood Platform

HEM-BLD-RX-020

Universal Synthetic Blood Platform

SECTION XIV — PROJECT RHENOVA INTEGRATION

Integrated With:

Universal Blood Cell Atlas
Universal Blood EV Atlas
Universal Blood Communication Connectome
Universal Hematopoietic Regeneration Atlas
Human Organ Communication Connectome
Whole-Body EV Simulation Engine
Digital Twin Architecture

TRANSLATIONAL DEVELOPMENT ROADMAP

BLD-SYN-H1

Synthetic Component Development

BLD-SYN-H2

Preclinical Validation

BLD-SYN-H3

Integrated System Engineering

BLD-SYN-H4

Safety and Regulatory Translation

BLD-SYN-H5

Clinical Deployment

NEXT DELIVERABLE

HEMOREGEN-BLD-007 — Blood Digital Twin Platform

Will establish:

Patient-specific blood simulation architecture
Real-time blood intelligence systems
Predictive hematology modeling
Blood failure forecasting
Synthetic blood optimization engine
Precision blood medicine framework

MASTER REGISTRY INDEX

HEMOREGEN-BLD-006 — Synthetic Blood Engineering Blueprint

HEM-BLD-RX-016 — Synthetic Oxygen Carrier Platform

HEM-BLD-RX-017 — Synthetic Hemostasis Platform

HEM-BLD-RX-018 — Synthetic EV Communication Platform

HEM-BLD-RX-019 — Programmable Blood Platform

HEM-BLD-RX-020 — Universal Synthetic Blood Platform

HEMOREGEN-BLD-500 — Synthetic Blood Division

HEMOREGEN-BLD-000 — SCF Universal Blood Engineering Program

SCF-BLD-SYN-0001 — Synthetic Blood Engineering Framework

SCF-BLD-ARTIFICIAL-0001 — Artificial Blood Systems Architecture

SCF-BLD-PROGRAMMABLE-0001 — Programmable Blood Systems Blueprint

SCF-BLD-UNIVERSAL-0001 — Universal Synthetic Blood Framework

HEMOREGEN-721-PROG-0001 — Project HEMOREGEN-721 Master Program